Expansion

Switzerland’s ALSO expands US business through joint venture

The Swiss technology distributor is extending its US presence through a joint venture, following the launch of cloud operations in February 2025.

Scaling in America Editorial15 Nov 2026
Switzerland→U.S.
Company: ALSO
Illustration for: ALSO expands US business through joint venture
Illustration for: ALSO expands US business through joint venture

Swiss technology distributor ALSO is expanding its US business through a joint venture, according to a MarketScreener report published on November 12, 2026. The move builds on cloud operations launched in February 2025.

The expansion represents a further step in ALSO’s American business rather than its first entry into the market. The reported sequence places the joint venture roughly 21 months after the launch of its US cloud operations.

A partnership-led next step

The strategic distinction is the use of a joint venture to extend an existing presence. That points to a partnership-led route for this stage of expansion, although the available information does not establish what capabilities, customers or market access the venture will add.

The available report summary does not identify the joint-venture partner, ownership structure, investment amount or US location. It also does not specify whether the venture will focus on cloud services or other parts of technology distribution.

Those details will be central to assessing the move’s scale and competitive significance. For now, the supported conclusion is narrower: ALSO is extending its US business beyond its initial cloud launch, with a joint venture as the next expansion vehicle.

ALSOSwitzerlandUS expansionJoint ventureCloud

Related Stories

Keep reading
Lonza agrees to buy five Merck sites, more than doubling US network
Illustration for: Novo-backed Windward Bio targets $1 billion valuation in US IPO
Funding

Windward Bio targets near-$1bn valuation in US IPO

Basel-based Windward Bio plans a Nasdaq IPO that would value it at nearly $1 billion, bringing its long-acting respiratory and dermatology drug pipeline to US public investors.

Switzerland→U.S.

11 Nov 2026

Illustration for: Austrian skin care company opens Roanoke headquarters